Biomaterials Market Segmentation:
End use Industry Segment Analysis
In the end use industry, hospitals and clinics is the dominating segment and is expected to hold the market share of 46.7% by 2037. The end use industry in the market serves in orthopedics cardiovascular care, wound healing, dental, and neurology, holds the largest share. The primary source of curing systems are hospital and surgical centers, making the primary consumers' demand for implantable biomaterials, including bone grafts, scaffolds, and drug delivery systems. The dental industry is also experiencing a rise due to cosmetic and restorative procedures as these surgeries use bioresorbable membranes and fillers.
Type Segment Analysis
In the type segment, synthetic biomaterials sub-segment accounts for a considerable market share of 43.6% in the market by 2037. The synthetic biomaterials such as PLA, PEG, and PMMA provide a stronger mechanical properties, scalability, and controlled dehydration. As per the National Library of Medicine, in drug delivery and tissue scaffolding, the synthetic polymers are used due to their customizable properties. Furthermore, synthetic biomaterials speed up their market clearance throughout the EU by facilitating compliance with the Medical Device Regulation, according to the European Medicines Agency.
Our in-depth analysis of the global biomaterials market includes the following segments:
|
Segment |
Subsegment |
|
Type |
|
|
Application |
|
|
End user |
|
